La hemostasia en el embarazo

Revista Cubana de Hematologia, Inmunologia y Hemoterapia

Volumn 16, Issue 2, 2000, Pages 90-98

  Vázquez, Delfina Almagro ^a  

^a INSTITUTO DE HEMATOLOGÍA E INMUNOLOGÍA   (Cuba)

Author keywords

Blood platelets; Fibrinolysis; Hemostatics; Pregnancy complications, hematologic

Indexed keywords

EID: 33847339957     PISSN: 08640289     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Pajor A, Lehoczky D. Splenec thrombosis complicating pregnancy in patients with poor obstetrical outcome. A report of four cases. Ann Hematol 1993;66:319-21.
2. Bick RL. Disseminated intravascular coagulation: objective criteria for clinical and laboratory diagnosis and assessment of therapeutic response. Clin Appl Thromb Hemost 1995;:3-23.
3. Seegers WM. Factors in the control of bleeding. Cincinnati J Med 1950;31:395-401.
4. Angelov A. Intravascular coagulation in relation to pregnancy and delivery. Zentralbe Gynakol 1989;111:1169-75.
5. Gilabert J, Estelles A, Aznar J, Espańa F, Vila J, Galbis M. Problemas trombóticos enobstetriciay ginecología. Rev Iberoam Tromb Hemost 1991;4:1-5.
6. Greer IA. The problem and profilaxis of thromboembolism in pregnancy. Curr Med Lit 1991;1:131-4.
7. Bergqvist A, Bergqvist D, Hallbrook T. Deep vein thrombosis during pregnancy. Acta Obstet Gynecol Scand 1983;62:443-8.
8. _ . Acute deep venous thrombosis after caesarean section. Acta Obstet Gynecol Scand 1979;58:473-5.
9. Letsky E, Swiet M. Thromboembolism in pregnancy and its management. Br J Haematol 1984;57:543-52.
10. Douketis JD, Ginsberg JS. Diagnostic problems with venous thromboembolism disease in pregnancy. Haemost 1995;25:58-71.
11. Aaro LA, Juergens JL. Thrombophlebitis associated with pregnancy. Am J Obstet Gynecol 1971;109:1128-33.
12. Ginsberg JS, Brill-Edwaeds P, Burrows RF. Venous thrombosis during pregnancy: leg and trimester of presentation. Thromb Haemost 1992;67:519-20.
13. Hellgren M, Svensson PJ, Dahlbäck B. Resistance to activated protein C as basis for venous thromboembolism associated with pregnancy and oral contraceptives. Am J Obstet Gynecol 1995;173:210-3.
14. Dahlback P, Hildebrand B. Inherited resistance to activated protein C is corrected by anticoagulant cofactor activity found to be property of factor V. Proc Natl Acad Sci USA 1994;91:1396-1400.
15. Bertina R, Koeleman SPC, Koster T. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994;369:64-7.
16. Kalafatis M, Rand MD, Man KG. The mechanism of activation of human V and human factor Va by activated protein C. J Biol Chem 1994;269:31869-75.
17. Dahlback B. Resistance to activated protein C caused by a common factor V gene mutation is a major risk factor for venous thrombosis. Rev Iberoam Tromb Hemost 1996;9:1-6.
18. Griffin JH, Evatt B, Wideman C, Fernández JA. Anticoagulant protein C pathway defective in majority of thrombophilic patients. Blood 1993;82:1989-93.
19. Weiner-Megnazi Z, Ben-Shlomo Y, Goldberg Y, Shalev E. Resistance to activated protein C and the Leiden mutation: high prevalence in patients with abruptio placentae. J Obstet Gynecol 1998;179:1565-7.
20. Decker GA, Vries JI de, Dorlitzsch PM, Hvijgens PC, Blomberg BM von, Jakobs C, et al. Underlying disorders associated with severe early-onset preeclampsia. Am J Obstet Gynecol 1995;173:1042-8.
21. 506 mutation (activated protein C resistance) associated with reduced intrapartum blood loss a possible evolutionary selection mechanism. Thromb Haemost 1998;79:69-73.
22. Wilhelmsen L, Svardsudd K, Korsan-Bergten K, Larsson B, Welin L, Tibblin G. Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med 1984;311:943-5.
23. Moller L, Kristensen TS. Plasma fibrinogen and ischemic heart disease risk factos. Arterioscl Thromb 1991;11:344-50.
24. Potron G, Ngoyen P, Pignon B. Fibrinogen arterial risk in clinical practice. Clin Hemorrh 1994;14:739-67.
25. Dalaker K, Smith P, Arnesen H, Prydz H. Factor VII-phospholipid complex in male survivors of acute myocardial infarction. Ach Med Scand 1987;222:111-6.
26. Koster T, Blann AD, Briet E, Vandenbroucke JP, Rosendeal FR. Role of clotting factor VIII effect of von Willebrand factor in occurrence of deep vein thrombosis. Lancet 1995;345:152-5.
27. Mak M. Coagulation fibrinolysis platelet and kinin forming system during toxemia of pregnancy. Biol Res Pregan 1983;4:152-4.
28. Reyes M, Gil R. Balance coagulación-fibrinolisis en el embarazo y postparto. Sangre 1991;36: Suppl 2:129.
29. Mannucci PM, Vigano S. Deficiencies of protein C an inhibitor of blood coagulation. Lancet 1982;2:463-7.
30. Comp PC, Thurnay GR, Welson J, Esman CT. Functional and inmunologic protein S levels are decreased during pregnancy. Blood 1988;68:881-5.
31. 1. Preissner KT. Biological relevance of the protein C system and laboratory diagnosis of protein C and protein S deficiencies. Clin Sci 1990;78:351-64.
32. Almagro D. Estados de hipercoagulabilidad. Rev Cub Hematol Inmunol Hemoter 1997;13:90-108.
33. Bertina PM. Hereditary protein S deficiency. Haemostasia 1988;15:241-6.
34. De Stefano V, Finazzi G, Mannucci PM. Inherited thrombophilia pathogenesis clinical syndromes and management. Blood 1996;87:3531-44.
35. Munster M, Guidpzii F, Jacobson BF. Thrombophilia profiles in normal pregnancies. Abstractr XVIth Congress of the International Society on Thrombosis and Haemostasis, 1997:266.
36. Shimada H, Ikeuchi M, Ihara Y, Hoshiro T, Sniotani M, Takasghina E, et al. Changes of plasma concentrations of tissue factor and tissue factor pathway inhibitor during pregnancy and Puerperium. Abstract XVIth Congress of the International Society on Thrombosis and Haemostasis, 1997:730.
37. Mc Kay OG. Chronic intravascular coagulation in normal pregnancy and preeclampsia. Cont Nephrol 1981;26:108-19.
38. Mc Kenzie IZ, Mac Lean OKI, Mitchell MD. Prostaglandins in the human fetal circulation in midtrimester and term pregnancy. Prostaglandins 1980;20:649-52.
39. Lewis PJ, Boglan P, Friedman BA, Hensby CN, Downing Y. Prostacyclin in pregnancy. Br Med J 1980; 282:1581-4.
40. Briel RC, Kieback DG, Lippert TH. Platelet sensitivity to a prostacyclin analogous in normal and pathological pregnancy. Prost Leuk Med 1984;13:335-40.
41. Almagro D. La hemostasia en el embarazo normal. En: la hemostasis en las complicaciones obstétricas. La Habana: Editorial Ciencias Médicas, 1997:9-19.
42. 1 foskolin). Biochem Biophys Res Commun 1983;113:598-602.
43. Kser-Glanzmann R, Jakabova M, George JN, Luscher EF. Stimulation of calcium uptake in platelet membrane vesicles by cAMP and protein kinase. Biochem Biophys Acta 1977;466:429-34.
44. Authi KS, Crawford N. Inositol 1 4 5-Triphosphate-induced release of sequestered Ca++ from highly purified human platelet intracelular membranes. Biochem J 1985;230:247-52.
45. Flores A. Trombocitopenia y gestación. Med Clin 1996;107:735-7.
46. Burrows RF, Kelton JG. Fetal thrombocytopenia and its relation to maternal thrombocytopenia. N Engl J Med 1993;329:1463-6.
47. Altes A, Muñíz-Díaz E, Pujol-Moix N, Matero J, Fontcuberla J, Parra J, et al. Tromcitopenia aislada en el curso de la gestación. Estudio etiopatogénico y actitud terapéutica en 60 pacientes. Med Clin 1996;107:721-5.
48. Boehlen F, Hohlfeld P, Extermann P, de Moerloose P Incidence of maternal thrombocytopenia and characterization of maternal antiplatelet antibodies (MAIPA). Abstract XVIth Congress of the International Society on Thrombosis and Haemostasis, 1907:735.
49. Fay RA, Hughes AO, Farron NT. Platelets in pregnancy: hyperdestruction in pregnancy. Obstet Gynecol 1983;61:23840.
50. Gerbas FR, Bottoms S, Farag A, Mammen E. Increased intravascular coagulation associated with pregnancy. Obstet Gynecol 1990;75:385-9.
51. Reyes M, Gil R. Estudio de la relación entre los niveles de t-PA, PAI-1 y PAI-2 durante el embarazo y postparto. Sangre 1991;36: Suppl 2, 129.
52. Bonnar J. Blood coagulation and fibrinolysis in human pregnancy. Bibl Anat 1973;12:58-63.
53. Gow Y, Campbell DM, Ogston D. The fibrinolytic system in pre-eclampsia. J Clin Pathol 1984;37:56-8.